| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 173,664 | 61,274 | | Cost of Revenue | 54,904 | 888 | | | Gross Profit | 118,760 | 60,386 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 19,571 | 214,244 | | Non Recurring |
-
|
-
| | Others | 50,703 | 17,315 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 48,486 | (171,173) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 308 | 412 | | Earnings Before Interest And Taxes | 31,716 | (83,519) | | Interest Expense | 12,634 | 17,406 | | Income Before Tax | 19,082 | (100,925) | | Income Tax Expense |
-
|
-
| | Minority Interest | (17,078) | 87,242 | | | | Net Income From Continuing Ops | 19,082 | (100,925) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 19,082 | (100,925) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $19,082 | ($100,925) |
|
0.51% Nasdaq 
Income Statement
